Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.43 EUR
−55.80 M EUR
0.00 EUR
15.23 M
About Outlook Therapeutics, Inc.
Sector
CEO
C. Russell Trenary
Headquarters
Iselin
Website
Founded
2010
FIGI
BBG00NK8G7N1
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 41O is 1.67 EUR — it has decreased by −64.68% in the past 24 hours. Watch OUTLOOK THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange OUTLOOK THERAPEUTICS INC stocks are traded under the ticker 41O.
41O stock has fallen by −65.98% compared to the previous week, the month change is a −66.80% fall, over the last year OUTLOOK THERAPEUTICS INC has showed a −78.57% decrease.
We've gathered analysts' opinions on OUTLOOK THERAPEUTICS INC future price: according to them, 41O price has a max estimate of 50.54 EUR and a min estimate of 8.58 EUR. Watch 41O chart and read a more detailed OUTLOOK THERAPEUTICS INC stock forecast: see what analysts think of OUTLOOK THERAPEUTICS INC and suggest that you do with its stocks.
41O stock is 8.44% volatile and has beta coefficient of 0.36. Track OUTLOOK THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is OUTLOOK THERAPEUTICS INC there?
Today OUTLOOK THERAPEUTICS INC has the market capitalization of 109.49 M, it has decreased by −4.58% over the last week.
Yes, you can track OUTLOOK THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
OUTLOOK THERAPEUTICS INC is going to release the next earnings report on Dec 19, 2024. Keep track of upcoming events with our Earnings Calendar.
41O earnings for the last quarter are −0.77 EUR per share, whereas the estimation was −0.96 EUR resulting in a 19.64% surprise. The estimated earnings for the next quarter are −0.72 EUR per share. See more details about OUTLOOK THERAPEUTICS INC earnings.
OUTLOOK THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
41O net income for the last quarter is 41.46 M EUR, while the quarter before that showed −105.92 M EUR of net income which accounts for 139.14% change. Track more OUTLOOK THERAPEUTICS INC financial stats to get the full picture.
No, 41O doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 24.00 employees. See our rating of the largest employees — is OUTLOOK THERAPEUTICS INC on this list?
Like other stocks, 41O shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OUTLOOK THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.